tiprankstipranks
Trending News
More News >
Allogene Therapeutics Inc (ALLO)
NASDAQ:ALLO
US Market

Allogene Therapeutics (ALLO) Ownership - Who Owns Allogene Therapeutics?

Compare
1,430 Followers

Allogene Therapeutics (ALLO) Ownership Overview

10.77%18.41%47.35%7.94%15.53%
10.77% Insiders
47.35% Other Institutional Investors
7.94% ETFs
15.53% Public Companies and Individual Investors
The ownership structure of Allogene Therapeutics (ALLO) stock is a mix of institutional, retail, and individual investors. Approximately 73.69% of the company’s stock is owned by Institutional Investors, 10.77% is owned by Insiders, and 15.53% is owned by Public Companies and Individual Investors.
The ownership structure of Allogene Therapeutics (ALLO) stock is a mix of institutional, retail, and individual investors. Approximately 65.76% of the company’s stock is owned by Institutional Investors, 10.77% is owned by Insiders, and 7.94% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 10, 2024
xxxxxxxxxxxxx
$19916
Dec 09, 2024
xxxxxxxxxxxxx
$19917

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$6366487
Mar 31, 2025
xxxxxxxxxxxxx
$7200486

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
11,009,103Insider5.03%12,220,104
8,189,765Insider3.74%9,090,639
7,827,665Institution3.58%8,688,708
6,896,552Institution3.15%7,655,173
6,437,102Institution2.94%7,145,183
6,287,488Institution2.87%6,979,112
4,931,840Institution2.25%5,474,342
4,360,608Institution1.99%4,840,275
3,265,529Institution1.49%3,624,737
3,169,230Institution1.45%3,517,845

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
6,896,552Institution3.15%7,655,173
6,437,102Institution2.94%7,145,183
3,265,529Institution1.49%3,624,737
3,169,230Institution1.45%3,517,845
2,969,370Institution1.36%3,296,001
2,500,000Institution1.14%2,775,000
2,204,834Institution1.01%2,447,366
1,827,970Institution0.84%2,029,047
1,741,870Institution0.80%1,933,476
1,463,721Institution0.67%1,624,730

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,278,056Institution1.96%7,187,134
3,259,148Institution1.49%3,617,654
2,360,104Institution1.08%3,964,975
1,150,487Institution0.53%1,277,041
831,881Institution0.38%923,388
715,880Institution0.33%780,309
633,121Institution0.29%1,063,643
457,891Institution0.21%769,257
410,272Institution0.19%447,196
399,725Institution0.18%435,700

FAQ

Who Owns Allogene Therapeutics Inc (ALLO)?
According to the latest TipRanks data, approximately 47.35% of the company's stock is held by institutional investors, 10.77% is held by insiders, and 15.53% is held by retail investors.
    What percentage of Allogene Therapeutics Inc (ALLO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 47.35% of Allogene Therapeutics Inc (ALLO) stock is held by institutional investors.
      What percentage of Allogene Therapeutics Inc (ALLO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 15.53% of Allogene Therapeutics Inc (ALLO) stock is held by retail investors.
        Who owns the most shares of Allogene Therapeutics Inc (ALLO)?
        Arie Belldegrun owns the most shares of Allogene Therapeutics Inc (ALLO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis